Cover Image
Market Research Report
Product code
923494

Global Opioid Drugs Market Size, Status and Forecast 2020-2026

Published: | QYResearch | 95 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Opioid Drugs Market Size, Status and Forecast 2020-2026
Published: January 30, 2020
QYResearch
Content info: 95 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

Opioid Drugs can act on the pain central system in the human brain, brainstem and other tissues, thus exerting a strong downward pain suppression effect.

Opioid Drugs can not only bind to peripheral nerve opioid receptors, but also to opioid receptors in the gelatinous (second layer) sensory neurons of the spinal dorsal horn in the human body, and can also inhibit the Released, effectively preventing pain sensations from flowing into the brain.

Market Analysis and Insights: Global Opioid Drugs Market

In 2019, the global Opioid Drugs market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.

Global Opioid Drugs Scope and Market Size

Opioid Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Opioid Drugs market is segmented into Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol, Others, etc.

Segment by Application, the Opioid Drugs market is segmented into Anesthesia, Pain relief, Cough suppression, Diarrhea suppression, Deaddiction, Others, etc.

Regional and Country-level Analysis

The Opioid Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Opioid Drugs market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape and Opioid Drugs Market Share Analysis

Opioid Drugs market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Opioid Drugs business, the date to enter into the Opioid Drugs market, Opioid Drugs product introduction, recent developments, etc.

The major vendors include Acura Pharmaceuticals, Cipher Pharmaceutical Inc., Daiichi Sankyo, Johnson&Johnson, Lupin Limited, Pfizer, Sun Pharmaceuticals, Teva Pharmaceutical Industries Ltd., etc.

This report focuses on the global Opioid Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Opioid Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

  • Acura Pharmaceuticals
  • Cipher Pharmaceutical Inc.
  • Daiichi Sankyo
  • Johnson&Johnson
  • Lupin Limited
  • Pfizer
  • Sun Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.

Market segment by Type, the product can be split into

  • Buprenorphine
  • Fentanyl
  • Hydrocodone
  • Morphine
  • Oxycodone
  • Tramadol
  • Others

Market segment by Application, split into

  • Anesthesia
  • Pain relief
  • Cough suppression
  • Diarrhea suppression
  • Deaddiction
  • Others

Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Opioid Drugs status, future forecast, growth opportunity, key market and key players.
  • To present the Opioid Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

  • To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Opioid Drugs are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Opioid Drugs Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Opioid Drugs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Buprenorphine
    • 1.4.3 Fentanyl
    • 1.4.4 Hydrocodone
    • 1.4.5 Morphine
    • 1.4.6 Oxycodone
    • 1.4.7 Tramadol
    • 1.4.8 Others
  • 1.5 Market by Application
    • 1.5.1 Global Opioid Drugs Market Share by Application: 2020 VS 2026
    • 1.5.2 Anesthesia
    • 1.5.3 Pain relief
    • 1.5.4 Cough suppression
    • 1.5.5 Diarrhea suppression
    • 1.5.6 Deaddiction
    • 1.5.7 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Opioid Drugs Market Perspective (2015-2026)
  • 2.2 Opioid Drugs Growth Trends by Regions
    • 2.2.1 Opioid Drugs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Opioid Drugs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Opioid Drugs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter's Five Forces Analysis
    • 2.3.5 Opioid Drugs Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Opioid Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Opioid Drugs Players by Market Size
    • 3.1.1 Global Top Opioid Drugs Players by Revenue (2015-2020)
    • 3.1.2 Global Opioid Drugs Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Opioid Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Opioid Drugs Market Concentration Ratio
    • 3.2.1 Global Opioid Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Opioid Drugs Revenue in 2019
  • 3.3 Opioid Drugs Key Players Head office and Area Served
  • 3.4 Key Players Opioid Drugs Product Solution and Service
  • 3.5 Date of Enter into Opioid Drugs Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Opioid Drugs Historic Market Size by Type (2015-2020)
  • 4.2 Global Opioid Drugs Forecasted Market Size by Type (2021-2026)

5 Opioid Drugs Breakdown Data by Application (2015-2026)

  • 5.1 Global Opioid Drugs Market Size by Application (2015-2020)
  • 5.2 Global Opioid Drugs Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Opioid Drugs Market Size (2015-2020)
  • 6.2 Opioid Drugs Key Players in North America (2019-2020)
  • 6.3 North America Opioid Drugs Market Size by Type (2015-2020)
  • 6.4 North America Opioid Drugs Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Opioid Drugs Market Size (2015-2020)
  • 7.2 Opioid Drugs Key Players in Europe (2019-2020)
  • 7.3 Europe Opioid Drugs Market Size by Type (2015-2020)
  • 7.4 Europe Opioid Drugs Market Size by Application (2015-2020)

8 China

  • 8.1 China Opioid Drugs Market Size (2015-2020)
  • 8.2 Opioid Drugs Key Players in China (2019-2020)
  • 8.3 China Opioid Drugs Market Size by Type (2015-2020)
  • 8.4 China Opioid Drugs Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Opioid Drugs Market Size (2015-2020)
  • 9.2 Opioid Drugs Key Players in Japan (2019-2020)
  • 9.3 Japan Opioid Drugs Market Size by Type (2015-2020)
  • 9.4 Japan Opioid Drugs Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Opioid Drugs Market Size (2015-2020)
  • 10.2 Opioid Drugs Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Opioid Drugs Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Opioid Drugs Market Size by Application (2015-2020)

11 India

  • 11.1 India Opioid Drugs Market Size (2015-2020)
  • 11.2 Opioid Drugs Key Players in India (2019-2020)
  • 11.3 India Opioid Drugs Market Size by Type (2015-2020)
  • 11.4 India Opioid Drugs Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Opioid Drugs Market Size (2015-2020)
  • 12.2 Opioid Drugs Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Opioid Drugs Market Size by Type (2015-2020)
  • 12.4 Central & South America Opioid Drugs Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Acura Pharmaceuticals
    • 13.1.1 Acura Pharmaceuticals Company Details
    • 13.1.2 Acura Pharmaceuticals Business Overview and Its Total Revenue
    • 13.1.3 Acura Pharmaceuticals Opioid Drugs Introduction
    • 13.1.4 Acura Pharmaceuticals Revenue in Opioid Drugs Business (2015-2020))
    • 13.1.5 Acura Pharmaceuticals Recent Development
  • 13.2 Cipher Pharmaceutical Inc.
    • 13.2.1 Cipher Pharmaceutical Inc. Company Details
    • 13.2.2 Cipher Pharmaceutical Inc. Business Overview and Its Total Revenue
    • 13.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Introduction
    • 13.2.4 Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2015-2020)
    • 13.2.5 Cipher Pharmaceutical Inc. Recent Development
  • 13.3 Daiichi Sankyo
    • 13.3.1 Daiichi Sankyo Company Details
    • 13.3.2 Daiichi Sankyo Business Overview and Its Total Revenue
    • 13.3.3 Daiichi Sankyo Opioid Drugs Introduction
    • 13.3.4 Daiichi Sankyo Revenue in Opioid Drugs Business (2015-2020)
    • 13.3.5 Daiichi Sankyo Recent Development
  • 13.4 Johnson&Johnson
    • 13.4.1 Johnson&Johnson Company Details
    • 13.4.2 Johnson&Johnson Business Overview and Its Total Revenue
    • 13.4.3 Johnson&Johnson Opioid Drugs Introduction
    • 13.4.4 Johnson&Johnson Revenue in Opioid Drugs Business (2015-2020)
    • 13.4.5 Johnson&Johnson Recent Development
  • 13.5 Lupin Limited
    • 13.5.1 Lupin Limited Company Details
    • 13.5.2 Lupin Limited Business Overview and Its Total Revenue
    • 13.5.3 Lupin Limited Opioid Drugs Introduction
    • 13.5.4 Lupin Limited Revenue in Opioid Drugs Business (2015-2020)
    • 13.5.5 Lupin Limited Recent Development
  • 13.6 Pfizer
    • 13.6.1 Pfizer Company Details
    • 13.6.2 Pfizer Business Overview and Its Total Revenue
    • 13.6.3 Pfizer Opioid Drugs Introduction
    • 13.6.4 Pfizer Revenue in Opioid Drugs Business (2015-2020)
    • 13.6.5 Pfizer Recent Development
  • 13.7 Sun Pharmaceuticals
    • 13.7.1 Sun Pharmaceuticals Company Details
    • 13.7.2 Sun Pharmaceuticals Business Overview and Its Total Revenue
    • 13.7.3 Sun Pharmaceuticals Opioid Drugs Introduction
    • 13.7.4 Sun Pharmaceuticals Revenue in Opioid Drugs Business (2015-2020)
    • 13.7.5 Sun Pharmaceuticals Recent Development
  • 13.8 Teva Pharmaceutical Industries Ltd.
    • 13.8.1 Teva Pharmaceutical Industries Ltd. Company Details
    • 13.8.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
    • 13.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Introduction
    • 13.8.4 Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2015-2020)
    • 13.8.5 Teva Pharmaceutical Industries Ltd. Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Disclaimer
  • 15.3 Author Details

List of Tables

  • Table 1. Opioid Drugs Key Market Segments
  • Table 2. Key Players Covered: Ranking by Opioid Drugs Revenue
  • Table 3. Ranking of Global Top Opioid Drugs Manufacturers by Revenue (US$ Million) in 2019
  • Table 4. Global Opioid Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
  • Table 5. Key Players of Buprenorphine
  • Table 6. Key Players of Fentanyl
  • Table 7. Key Players of Hydrocodone
  • Table 8. Key Players of Morphine
  • Table 9. Key Players of Oxycodone
  • Table 10. Key Players of Tramadol
  • Table 11. Key Players of Others
  • Table 12. Global Opioid Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
  • Table 13. Global Opioid Drugs Market Size by Regions (US$ Million): 2020 VS 2026
  • Table 14. Global Opioid Drugs Market Size by Regions (2015-2020) (US$ Million)
  • Table 15. Global Opioid Drugs Market Share by Regions (2015-2020)
  • Table 16. Global Opioid Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
  • Table 17. Global Opioid Drugs Market Share by Regions (2021-2026)
  • Table 18. Market Top Trends
  • Table 19. Key Drivers: Impact Analysis
  • Table 20. Key Challenges
  • Table 21. Opioid Drugs Market Growth Strategy
  • Table 22. Main Points Interviewed from Key Opioid Drugs Players
  • Table 23. Global Opioid Drugs Revenue by Players (2015-2020) (Million US$)
  • Table 24. Global Opioid Drugs Market Share by Players (2015-2020)
  • Table 25. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Drugs as of 2019)
  • Table 26. Global Opioid Drugs by Players Market Concentration Ratio (CR5 and HHI)
  • Table 27. Key Players Headquarters and Area Served
  • Table 28. Key Players Opioid Drugs Product Solution and Service
  • Table 29. Date of Enter into Opioid Drugs Market
  • Table 30. Mergers & Acquisitions, Expansion Plans
  • Table 31. Global Opioid Drugs Market Size by Type (2015-2020) (Million US$)
  • Table 32. Global Opioid Drugs Market Size Share by Type (2015-2020)
  • Table 33. Global Opioid Drugs Revenue Market Share by Type (2021-2026)
  • Table 34. Global Opioid Drugs Market Size Share by Application (2015-2020)
  • Table 35. Global Opioid Drugs Market Size by Application (2015-2020) (Million US$)
  • Table 36. Global Opioid Drugs Market Size Share by Application (2021-2026)
  • Table 37. North America Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
  • Table 38. North America Key Players Opioid Drugs Market Share (2019-2020)
  • Table 39. North America Opioid Drugs Market Size by Type (2015-2020) (Million US$)
  • Table 40. North America Opioid Drugs Market Share by Type (2015-2020)
  • Table 41. North America Opioid Drugs Market Size by Application (2015-2020) (Million US$)
  • Table 42. North America Opioid Drugs Market Share by Application (2015-2020)
  • Table 43. Europe Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
  • Table 44. Europe Key Players Opioid Drugs Market Share (2019-2020)
  • Table 45. Europe Opioid Drugs Market Size by Type (2015-2020) (Million US$)
  • Table 46. Europe Opioid Drugs Market Share by Type (2015-2020)
  • Table 47. Europe Opioid Drugs Market Size by Application (2015-2020) (Million US$)
  • Table 48. Europe Opioid Drugs Market Share by Application (2015-2020)
  • Table 49. China Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
  • Table 50. China Key Players Opioid Drugs Market Share (2019-2020)
  • Table 51. China Opioid Drugs Market Size by Type (2015-2020) (Million US$)
  • Table 52. China Opioid Drugs Market Share by Type (2015-2020)
  • Table 53. China Opioid Drugs Market Size by Application (2015-2020) (Million US$)
  • Table 54. China Opioid Drugs Market Share by Application (2015-2020)
  • Table 55. Japan Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
  • Table 56. Japan Key Players Opioid Drugs Market Share (2019-2020)
  • Table 57. Japan Opioid Drugs Market Size by Type (2015-2020) (Million US$)
  • Table 58. Japan Opioid Drugs Market Share by Type (2015-2020)
  • Table 59. Japan Opioid Drugs Market Size by Application (2015-2020) (Million US$)
  • Table 60. Japan Opioid Drugs Market Share by Application (2015-2020)
  • Table 61. Southeast Asia Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
  • Table 62. Southeast Asia Key Players Opioid Drugs Market Share (2019-2020)
  • Table 63. Southeast Asia Opioid Drugs Market Size by Type (2015-2020) (Million US$)
  • Table 64. Southeast Asia Opioid Drugs Market Share by Type (2015-2020)
  • Table 65. Southeast Asia Opioid Drugs Market Size by Application (2015-2020) (Million US$)
  • Table 66. Southeast Asia Opioid Drugs Market Share by Application (2015-2020)
  • Table 67. India Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
  • Table 68. India Key Players Opioid Drugs Market Share (2019-2020)
  • Table 69. India Opioid Drugs Market Size by Type (2015-2020) (Million US$)
  • Table 70. India Opioid Drugs Market Share by Type (2015-2020)
  • Table 71. India Opioid Drugs Market Size by Application (2015-2020) (Million US$)
  • Table 72. India Opioid Drugs Market Share by Application (2015-2020)
  • Table 73. Central & South America Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
  • Table 74. Central & South America Key Players Opioid Drugs Market Share (2019-2020)
  • Table 75. Central & South America Opioid Drugs Market Size by Type (2015-2020) (Million US$)
  • Table 76. Central & South America Opioid Drugs Market Share by Type (2015-2020)
  • Table 77. Central & South America Opioid Drugs Market Size by Application (2015-2020) (Million US$)
  • Table 78. Central & South America Opioid Drugs Market Share by Application (2015-2020)
  • Table 79. Acura Pharmaceuticals Company Details
  • Table 80. Acura Pharmaceuticals Business Overview
  • Table 81. Acura Pharmaceuticals Product
  • Table 82. Acura Pharmaceuticals Revenue in Opioid Drugs Business (2015-2020) (Million US$)
  • Table 83. Acura Pharmaceuticals Recent Development
  • Table 84. Cipher Pharmaceutical Inc. Company Details
  • Table 85. Cipher Pharmaceutical Inc. Business Overview
  • Table 86. Cipher Pharmaceutical Inc. Product
  • Table 87. Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2015-2020) (Million US$)
  • Table 88. Cipher Pharmaceutical Inc. Recent Development
  • Table 89. Daiichi Sankyo Company Details
  • Table 90. Daiichi Sankyo Business Overview
  • Table 91. Daiichi Sankyo Product
  • Table 92. Daiichi Sankyo Revenue in Opioid Drugs Business (2015-2020) (Million US$)
  • Table 93. Daiichi Sankyo Recent Development
  • Table 94. Johnson&Johnson Company Details
  • Table 95. Johnson&Johnson Business Overview
  • Table 96. Johnson&Johnson Product
  • Table 97. Johnson&Johnson Revenue in Opioid Drugs Business (2015-2020) (Million US$)
  • Table 98. Johnson&Johnson Recent Development
  • Table 99. Lupin Limited Company Details
  • Table 100. Lupin Limited Business Overview
  • Table 101. Lupin Limited Product
  • Table 102. Lupin Limited Revenue in Opioid Drugs Business (2015-2020) (Million US$)
  • Table 103. Lupin Limited Recent Development
  • Table 104. Pfizer Company Details
  • Table 105. Pfizer Business Overview
  • Table 106. Pfizer Product
  • Table 107. Pfizer Revenue in Opioid Drugs Business (2015-2020) (Million US$)
  • Table 108. Pfizer Recent Development
  • Table 109. Sun Pharmaceuticals Company Details
  • Table 110. Sun Pharmaceuticals Business Overview
  • Table 111. Sun Pharmaceuticals Product
  • Table 112. Sun Pharmaceuticals Revenue in Opioid Drugs Business (2015-2020) (Million US$)
  • Table 113. Sun Pharmaceuticals Recent Development
  • Table 114. Teva Pharmaceutical Industries Ltd. Business Overview
  • Table 115. Teva Pharmaceutical Industries Ltd. Product
  • Table 116. Teva Pharmaceutical Industries Ltd. Company Details
  • Table 117. Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2015-2020) (Million US$)
  • Table 118. Teva Pharmaceutical Industries Ltd. Recent Development
  • Table 119. Research Programs/Design for This Report
  • Table 120. Key Data Information from Secondary Sources
  • Table 121. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Opioid Drugs Market Share by Type: 2020 VS 2026
  • Figure 2. Buprenorphine Features
  • Figure 3. Fentanyl Features
  • Figure 4. Hydrocodone Features
  • Figure 5. Morphine Features
  • Figure 6. Oxycodone Features
  • Figure 7. Tramadol Features
  • Figure 8. Others Features
  • Figure 9. Global Opioid Drugs Market Share by Application: 2020 VS 2026
  • Figure 10. Anesthesia Case Studies
  • Figure 11. Pain relief Case Studies
  • Figure 12. Cough suppression Case Studies
  • Figure 13. Diarrhea suppression Case Studies
  • Figure 14. Deaddiction Case Studies
  • Figure 15. Others Case Studies
  • Figure 16. Opioid Drugs Report Years Considered
  • Figure 17. Global Opioid Drugs Market Size YoY Growth 2015-2026 (US$ Million)
  • Figure 18. Global Opioid Drugs Market Share by Regions: 2020 VS 2026
  • Figure 19. Global Opioid Drugs Market Share by Regions (2021-2026)
  • Figure 20. Porter's Five Forces Analysis
  • Figure 21. Global Opioid Drugs Market Share by Players in 2019
  • Figure 22. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Drugs as of 2019
  • Figure 23. The Top 10 and 5 Players Market Share by Opioid Drugs Revenue in 2019
  • Figure 24. North America Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
  • Figure 25. Europe Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
  • Figure 26. China Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
  • Figure 27. Japan Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
  • Figure 28. Southeast Asia Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
  • Figure 29. India Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
  • Figure 30. Central & South America Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
  • Figure 31. Acura Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 32. Acura Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2015-2020)
  • Figure 33. Cipher Pharmaceutical Inc. Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 34. Cipher Pharmaceutical Inc. Revenue Growth Rate in Opioid Drugs Business (2015-2020)
  • Figure 35. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 36. Daiichi Sankyo Revenue Growth Rate in Opioid Drugs Business (2015-2020)
  • Figure 37. Johnson&Johnson Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 38. Johnson&Johnson Revenue Growth Rate in Opioid Drugs Business (2015-2020)
  • Figure 39. Lupin Limited Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 40. Lupin Limited Revenue Growth Rate in Opioid Drugs Business (2015-2020)
  • Figure 41. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 42. Pfizer Revenue Growth Rate in Opioid Drugs Business (2015-2020)
  • Figure 43. Sun Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 44. Sun Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2015-2020)
  • Figure 45. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 46. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Opioid Drugs Business (2015-2020)
  • Figure 47. Bottom-up and Top-down Approaches for This Report
  • Figure 48. Data Triangulation
  • Figure 49. Key Executives Interviewed